Blood supply and safety in the developing world: Considerations for emerging markets

William Riley, Jeffry McCullough

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Assuring a safe and adequate blood supply in developing nations such as emerging markets is a daunting challenge that directly affects fundamental health metrics of a country. Numerous mortalities can be reduced when an effective national blood transfusion system is in place. These mortalities include leading causes of death such as maternal hemorrhage, sickle cell anemia, and malaria. There exists a circular relationship between blood supply and safety: efforts to ensure donor and recipient safety reduce the population of eligible voluntary blood donors, which in turn restricts blood supply. In this article we describe the main issues for blood supply in developing nations and emerging markets, identify the major causes and impact of transfusion transmitted infections, present a safety model that describes the relationship between defensive barriers in depth to assure safe blood, its effectiveness, and the impact it has on safe blood supply. The results of this study apply to the forty seven nations sub-Saharan Africa (SSA) based on an extrapolation from a focused analysis on twenty two African countries. Finally, we discuss strategies for blood safety and supply in developing nations.

Original languageEnglish (US)
Pages (from-to)50-57
Number of pages8
JournalJournal of Commercial Biotechnology
Volume18
Issue number4
DOIs
StatePublished - Oct 2012
Externally publishedYes

Fingerprint

Blood Safety
Blood
Developing Countries
Safety
Mortality
Africa South of the Sahara
Sickle Cell Anemia
Blood Donors
Blood Transfusion
Malaria
Cause of Death
Mothers
Developing world
Emerging markets
Tissue Donors
Hemorrhage
Health
Extrapolation
Infection
Population

Keywords

  • Blood supply
  • Developing countries
  • Emerging markets
  • Patient safety

ASJC Scopus subject areas

  • Biotechnology
  • Management of Technology and Innovation
  • Economics and Econometrics

Cite this

Blood supply and safety in the developing world : Considerations for emerging markets. / Riley, William; McCullough, Jeffry.

In: Journal of Commercial Biotechnology, Vol. 18, No. 4, 10.2012, p. 50-57.

Research output: Contribution to journalArticle

@article{e0d488ae63cd4bd0a1151033e18a7835,
title = "Blood supply and safety in the developing world: Considerations for emerging markets",
abstract = "Assuring a safe and adequate blood supply in developing nations such as emerging markets is a daunting challenge that directly affects fundamental health metrics of a country. Numerous mortalities can be reduced when an effective national blood transfusion system is in place. These mortalities include leading causes of death such as maternal hemorrhage, sickle cell anemia, and malaria. There exists a circular relationship between blood supply and safety: efforts to ensure donor and recipient safety reduce the population of eligible voluntary blood donors, which in turn restricts blood supply. In this article we describe the main issues for blood supply in developing nations and emerging markets, identify the major causes and impact of transfusion transmitted infections, present a safety model that describes the relationship between defensive barriers in depth to assure safe blood, its effectiveness, and the impact it has on safe blood supply. The results of this study apply to the forty seven nations sub-Saharan Africa (SSA) based on an extrapolation from a focused analysis on twenty two African countries. Finally, we discuss strategies for blood safety and supply in developing nations.",
keywords = "Blood supply, Developing countries, Emerging markets, Patient safety",
author = "William Riley and Jeffry McCullough",
year = "2012",
month = "10",
doi = "10.5912/jcb.565",
language = "English (US)",
volume = "18",
pages = "50--57",
journal = "Journal of Commercial Biotechnology",
issn = "1462-8732",
publisher = "ThinkBiotech",
number = "4",

}

TY - JOUR

T1 - Blood supply and safety in the developing world

T2 - Considerations for emerging markets

AU - Riley, William

AU - McCullough, Jeffry

PY - 2012/10

Y1 - 2012/10

N2 - Assuring a safe and adequate blood supply in developing nations such as emerging markets is a daunting challenge that directly affects fundamental health metrics of a country. Numerous mortalities can be reduced when an effective national blood transfusion system is in place. These mortalities include leading causes of death such as maternal hemorrhage, sickle cell anemia, and malaria. There exists a circular relationship between blood supply and safety: efforts to ensure donor and recipient safety reduce the population of eligible voluntary blood donors, which in turn restricts blood supply. In this article we describe the main issues for blood supply in developing nations and emerging markets, identify the major causes and impact of transfusion transmitted infections, present a safety model that describes the relationship between defensive barriers in depth to assure safe blood, its effectiveness, and the impact it has on safe blood supply. The results of this study apply to the forty seven nations sub-Saharan Africa (SSA) based on an extrapolation from a focused analysis on twenty two African countries. Finally, we discuss strategies for blood safety and supply in developing nations.

AB - Assuring a safe and adequate blood supply in developing nations such as emerging markets is a daunting challenge that directly affects fundamental health metrics of a country. Numerous mortalities can be reduced when an effective national blood transfusion system is in place. These mortalities include leading causes of death such as maternal hemorrhage, sickle cell anemia, and malaria. There exists a circular relationship between blood supply and safety: efforts to ensure donor and recipient safety reduce the population of eligible voluntary blood donors, which in turn restricts blood supply. In this article we describe the main issues for blood supply in developing nations and emerging markets, identify the major causes and impact of transfusion transmitted infections, present a safety model that describes the relationship between defensive barriers in depth to assure safe blood, its effectiveness, and the impact it has on safe blood supply. The results of this study apply to the forty seven nations sub-Saharan Africa (SSA) based on an extrapolation from a focused analysis on twenty two African countries. Finally, we discuss strategies for blood safety and supply in developing nations.

KW - Blood supply

KW - Developing countries

KW - Emerging markets

KW - Patient safety

UR - http://www.scopus.com/inward/record.url?scp=84867602073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867602073&partnerID=8YFLogxK

U2 - 10.5912/jcb.565

DO - 10.5912/jcb.565

M3 - Article

AN - SCOPUS:84867602073

VL - 18

SP - 50

EP - 57

JO - Journal of Commercial Biotechnology

JF - Journal of Commercial Biotechnology

SN - 1462-8732

IS - 4

ER -